Inflammatory Bowel Diseases
Conditions
Keywords
Colonoscopy, Inflammatory Bowel Diseases
Brief summary
Clinical trial evaluating efficacy of bowel cleansing solutions in patients with Inflammatory Bowel Disease.
Detailed description
Simple blind, randomized study evaluating efficacy of 1LPEG vs 2L PEG vs 2L sodium picosulfate in bowel cleansing of patients diagnosed of Inflammatory Bowel Disease undergoing diagnostic or follow-up routine colonoscopy.
Interventions
Colonoscopy
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients between 18y and 90y * Patients with a diagnosis of IBD undergoing follow-up or screening colonoscopy
Exclusion criteria
* Patients \<18y or \>90y * Pregnant Women * Patients with a past history of inadequate bowel cleansing in a colonoscopy performed in the previous 12 months prior to initiation of study * Patients with a history of bowel resection * Patients undergoing therapeutic colonoscopy * Patients unable to understand study protocol
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Bowel cleansing | 1 year | Boston Bowel Preparation Score (BBPS), a 10-point scale assessing bowel preparation after all cleansing maneuvers are completed by the endoscopist. Each region of the colon receives a segment score from 0 to 3 and these segment scores are summed for a total BBPS score ranging from 0 to 9. Therefore, the maximum BBPS score for a perfectly clean colon without any residual liquid is 9 and the minimum BBPS score for an unprepared colon is 0. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Treatment related adverse events | 1 year | Number of Participants with symptomatology related to intervention in each arm of the study |
| Preparation Tolerability: total volume of solution finally taken by the patient | 1 year | Evaluation of total volume of solution finally taken by the patient |
Countries
Spain